Comparative Research Spending
Idiopathic Pulmonary Fibrosis (IPF) is one of the most common forms of interstitial lung disease—yet the spending per patient is a fraction of what is spent on other diseases.
There are about 80,000 patients with IPF in the United States, half of whom will not live longer than three years.
| USA Patients | New Cases Yearly | Research Spending | $/Patient | |
|---|---|---|---|---|
| Cystic Fibrosis | 30,000 | 1,000 | $131m | $4,366 |
| Lou Gehrig’s Disease - Amyotrophic Lateral Sclerosis (ALS) | 30,000 | 5,600 | $48m | $1,600 |
| Idiopathic Pulmonary Fibrosis | 83,000 | 31,000 | $18m | $217 |